Eric Xueyu Chen

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

Suzanne Richter, Philippe L. Bédard, Eric Xueyu Chen et al. · Investigational New Drugs · 2013 · 80 citations · Full text

Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma

Lillian L. Siu, John Waldron, Bingshu E. Chen et al. · JAMA Oncology · 2016 · 70 citations

Ketoconazole and Posaconazole Selectively Target HK2-expressing Glioblastoma Cells

Sameer Agnihotri, Sheila Mansouri, Kelly Burrell et al. · Clinical Cancer Research · 2018 · 66 citations · Full text

NRG/RTOG 1112: Randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC).

Laura A. Dawson, Kathryn Winter, Jennifer J. Knox et al. · Journal of Clinical Oncology · 2023 · 59 citations

Surgical Oncology, Pharmacotherapy, Surgery +18

CCTG CO.26 trial: A phase II randomized study of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with advanced refractory colorectal carcinoma (rCRC).

Eric Xueyu Chen, Derek J. Jonker, Hagen F. Kennecke et al. · Journal of Clinical Oncology · 2019 · 40 citations

Cancer Management, Immunology, D+t Vs Bsc +19